Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1971
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1976 1
1978 3
1979 1
1980 2
1981 1
1989 1
1990 8
1991 1
1992 4
1993 1
1994 2
1995 1
1996 6
1998 4
1999 3
2000 4
2001 1
2002 2
2003 3
2004 3
2005 2
2006 6
2007 1
2008 5
2009 5
2010 4
2011 4
2012 3
2013 2
2014 1
2015 1
2016 5
2017 5
2018 8
2019 4
2020 3
2021 4
2022 4
2024 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, Soelberg Sørensen P, Vermersch P, Chang P, Hamlett A, Musch B, Greenberg SJ; CLARITY Study Group. Giovannoni G, et al. N Engl J Med. 2010 Feb 4;362(5):416-26. doi: 10.1056/NEJMoa0902533. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089960 Free article. Clinical Trial.
Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT.
Cortese M, Munger KL, Martínez-Lapiscina EH, Barro C, Edan G, Freedman MS, Hartung HP, Montalbán X, Foley FW, Penner IK, Hemmer B, Fox EJ, Schippling S, Wicklein EM, Kappos L, Kuhle J, Ascherio A; BENEFIT Study Group. Cortese M, et al. Neurology. 2020 May 5;94(18):e1950-e1960. doi: 10.1212/WNL.0000000000009371. Epub 2020 Apr 16. Neurology. 2020. PMID: 32300060 Free PMC article. Clinical Trial.
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.
Montalban X, Vermersch P, Arnold DL, Bar-Or A, Cree BAC, Cross AH, Kubala Havrdova E, Kappos L, Stuve O, Wiendl H, Wolinsky JS, Dahlke F, Le Bolay C, Shen Loo L, Gopalakrishnan S, Hyvert Y, Javor A, Guehring H, Tenenbaum N, Tomic D; evolutionRMS investigators. Montalban X, et al. Lancet Neurol. 2024 Nov;23(11):1119-1132. doi: 10.1016/S1474-4422(24)00328-4. Epub 2024 Sep 19. Lancet Neurol. 2024. PMID: 39307151 Clinical Trial.
[Diabetic peripheral neuropathy].
Dive D, Lievens I, Moonen G, Wang FC. Dive D, et al. Rev Med Liege. 2005 May-Jun;60(5-6):490-7. Rev Med Liege. 2005. PMID: 16035316 Free article. Review. French.
Corticosteroids in the management of acute multiple sclerosis exacerbations.
Smets I, Van Deun L, Bohyn C, van Pesch V, Vanopdenbosch L, Dive D, Bissay V, Dubois B; Belgian Study Group for Multiple Sclerosis. Smets I, et al. Among authors: dive d. Acta Neurol Belg. 2017 Sep;117(3):623-633. doi: 10.1007/s13760-017-0772-0. Epub 2017 Apr 8. Acta Neurol Belg. 2017. PMID: 28391390 Review.
The antimalarial ferroquine: from bench to clinic.
Biot C, Nosten F, Fraisse L, Ter-Minassian D, Khalife J, Dive D. Biot C, et al. Among authors: dive d. Parasite. 2011 Aug;18(3):207-14. doi: 10.1051/parasite/2011183207. Parasite. 2011. PMID: 21894260 Free PMC article. Review.
Environmental and health risks of hydroquinone.
Devillers J, Boule P, Vasseur P, Prevot P, Steiman R, Seigle-Murandi F, Benoit-Guyod JL, Nendza M, Grioni C, Dive D, et al. Devillers J, et al. Among authors: dive d. Ecotoxicol Environ Saf. 1990 Jun;19(3):327-54. doi: 10.1016/0147-6513(90)90035-4. Ecotoxicol Environ Saf. 1990. PMID: 2194781 Review.
[Multiple sclerosis : therapy update].
Dive D, Dauby S, Lommers E, Hansen I, Maquet P. Dive D, et al. Rev Med Liege. 2020 May;75(5-6):382-385. Rev Med Liege. 2020. PMID: 32496684 Free article. French.
116 results